Back Open link
Reader View

Q1 results 2026: Tata Motors PV to Brainbees Solutions among companies to declare Q1 results today; full list here | Stock Market News

www.livemint.com · August 13, 2026 · 08:29

Q1 results 2026: More than 570 companies are scheduled to release their financial results for the quarter ending on 30 June 2026 (Q1 results 2026) on Thursday, 13 August, amid ongoing earnings season.

Tata Motors Passenger Vehicles, Max Healthcare Institute, Honasa Consumer, Brainbees Solutions, Ipca Laboratories, Jubilant FoodWorks, LG Electronics India, Awfis Space Solutions are among the companies to report their Q1 results FY27 today.

On Wednesday, Indian equities closed in the red, with the benchmark Nifty 50 slipping below the 24,500 mark. The Sensex declined 187.90 points, or 0.24%, to end the session at 77,966.35, while the Nifty 50 fell 35.75 points, or 0.15%, to settle at 24,435.95.

Brokerage firm Motilal Oswal said that the company's India PV outperformed industry growth with a solid 46% YoY growth, fueled by new launches of Sierra and Punch EV.

However, the brokerage firm expects a 290bp YoY contraction in margins due to commodity pressure.

“At JLR, wholesales declined 9% YoY due to supply constraints, including a fire at a major component supplier at the start of the quarter. Overall, we expect JLR’s margins to contract 860bp QoQ (390bp YoY) to 5.4%,” the firm said.

Brokerage firm Kotak Insitutional Equities expect Honasa’s reported topline to grow 24% YoY to ₹7.4 billion.

According to the firm, the negative impact from the Flipkart invoicing change (logistics costs netted off from sales; double-digit salience; will be lapping base from 2Q) is well offset by the Reginald acquisition, implying organic/LFL growth at 22% (200 bps lower than reported growth akin to last quarter).

Growth was led by sustained growth momentum in Mamaearth (in teens akin to past few quarters), with focus categories (70% salience) growing across channels, and sustained strong 25%+ YoY growth in new brands, led by DermaCo. Overall, Honasa’s strategic corrective initiatives are tracking well, with 2-year CAGR basis at 15.4% (versus 18%/~13.5% in 4Q/3Q).

Disclaimer: This story is for educational purposes only. Please consult with an investment advisor before making any investment decisions.

Vaamanaa covers business and stock market news. Started in 2020, she has been producing news on digital platforms for over 4.5 years now. She writes on markets, commodities, IPOs, and industry. She has worked for news channels like Jagran New Media and Business Insider India. You can reach out to her at vaamanaa.sethi@htdigital.in.

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.